News archive





23/09/24 – Sustainable funding required to protect early phase antibiotics R&D for TB and beyond.

The AMR Accelerator calls to action: European capacity for antibiotic R&D requires long-term funding



13/08/24 – PrIMAVeRa project publishes on contact network dynamics to prevent pathogen transmission in hospitals


